Combined in utero and juvenile exposure of mice to arsenate and atrazine in drinking water modulates gene expression and clonogenicity of myeloid progenitors

Toxicology Letters

Volumn 180, Issue 1, 2008, Pages 59-66

  Cimino Reale, Graziella ^a   Ferrario, Daniele ^a,b   Casati, Barbara ^a   Brustio, Roberta ^a   Diodovich, Cristina ^a   Collotta, Angelo ^a   Vahter, Marie ^b   Gribaldo, Laura ^a  

^a JOINT RESEARCH CENTRE   (Italy)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Arsenate; Atrazine; CFU GM; Estrogen receptors

Indexed keywords

ARSENIC ACID; ATRAZINE; DRINKING WATER; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CLONOGENESIS; COLONY FORMING UNIT GM; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

ADMINISTRATION, ORAL; ANIMALS; ARSENATES; ATRAZINE; BONE MARROW CELLS; CLONE CELLS; DRINKING; DRUG COMBINATIONS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HERBICIDES; MALE; MATERNAL EXPOSURE; MICE; MICE, INBRED STRAINS; MYELOID PROGENITOR CELLS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREGNANCY; RECEPTORS, ESTROGEN; RNA, MESSENGER; TERATOGENS;

MUS;

EID: 47049088737     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2008.06.005     Document Type: Article

References (59)

1. Agency for Toxic Substances and Disease Registry (ATSDR). Guidance manual for the assessment of joint toxic action chemical mixture (2004), ATSDR, Atlanta, GA
2. Anderson L.M., Diwan B.A., Fear N.T., and Roman E. Critical windows of exposure for children's health: cancer in human epidemiological studies and neoplasms in experimental animal models. Environ. Health Perspect. 108 (2000) 573-594
3. Bates M.N., Rey O.A., Biggs M.L., Hopenhayn C., Moore L.E., Kalman D., Steinmaus C., and Smith A.H. Case-control study of bladder cancer and exposure to arsenic in Argentina. Am. J. Epidemiol. 159 (2004) 381-389
4. Blaylock B.L., Holladay S.D., Comment C.E., Heindel J.J., and Luster M.I. Exposure to tetrachlorodibenzo-p-dioxin (TCDD) alters fetal thymocyte maturation. Toxicol. Appl. Pharmacol. 112 February (2) (1992) 207-213
5. Capellino S., Montagna P., Villaggio B., Sulli A., Soldano S., Ferrero S., Remorgida V., and Cutolo M. Role of estrogens in inflammatory response: expression of estrogen receptors in peritoneal fluid macrophages from endometriosis. Ann. N. Y. Acad. Sci. 1069 (2006) 263-267
6. Chen G.C., Guan L.S., Hu W.L., and Wang Z.Y. Functional repression of estrogen receptor a by arsenic trioxide in human breast cancer cells. Anticancer Res. 22 (2002) 633-638
7. Chen Y.C., Su H.J., Guo Y.L., Hsueh Y.M., Smith T.J., Ryan L.M., Lee M.S., and Christiani D.C. Arsenic methylation and bladder cancer risk in Taiwan. Cancer Causes Control 14 (2003) 303-310
8. Chow S.K., Chan J.Y., and Fung K.P. Suppression of cell proliferation and regulation of estrogen receptor alpha signaling pathway by arsenic trioxide on human breast cancer MCF-7 cells. J. Endocrinol. 182 (2004) 325-337
9. Concha G., Vogler G., Lezcano D., Nermell B., and Vahter M. Exposure to inorganic arsenic metabolites during early human development. Toxicol. Sci. 44 (1998) 185-190
10. Cooper R.L., Stoker T.E., Goldman J.M., Parrish M.B., and Tyrey L. Effect of atrazine on ovarian function in the rat. Reprod. Toxicol. 10 (1996) 257-264
11. Cooper R.L., Stoker T.E., Tyrey L., Goldman J.M., and McElroy W.K. Atrazine disrupts the hypothalamic control of pituitary-ovarian function. Toxicol. Sci. 53 2 (2000) 297-307
12. Dai E., Guan H., Liu L., Little S., McFadden G., Vaziri S., Cao H., Ivanova I.A., Bocksch L., and Lucas A. Serp-1, a viral anti-inflammatory serpin, regulates cellular serine proteinase and serpin responses to vascular injury. J. Biol. Chem. 278 (2003) 18563-18572
13. Davey J.C., Bodwell J.E., Gosse J.A., and Hamilton J.W. Arsenic as an endocrine disruptor: effects of arsenic on estrogen receptor-mediated gene expression in vivo and in cell culture. Toxicol. Sci. 98 1 (2007) 75-86
14. Filipov N.M., Pinchuk L.M., Boyd B.L., and Crittenden P.L. Immunotoxic effects of short-term atrazine exposure in young male C57BL/6 mice. Toxicol. Sci. 86 (2005) 324-332
15. Gressel J. Evolution of herbicide-resistant weeds. Ciba Found. Symp. 102 (1984) 73-93
16. Gribaldo L., Bueren J., Deldar A., Hokland P., Meredith C., Moneta D., Mosesso P., Parchment R., Parent-Massin D., Pessina A., San Roman J., and Schoeters G. The use of in vitro systems for evaluating haematotoxicity. Altern. Lab. Anim. 24 (1996) 211-231
17. Gribaldo L. Haematotoxicology: scientific basis and regulatory aspects. Altern. Lab. Anim. 2 (2002) 111-113. (review)
18. Gupta V., and Singh S.M. Gender dimorphism in the myeloid differentiation of bone marrow precursor cells in murine host bearing a T cell lymphoma. J. Reprod. Immunol. 74 (2007) 90-102
19. Holladay S.D. Prenatal immunotoxicant exposure and postnatal autoimmune disease. Environ. Health Perspect. 107 Suppl. 5 (1999) 687-691 (review)
20. Internal Agency for Research on Cancer. Some drinking water disinfectant and contaminants, including arsenic. IARC Monogr. Eval. Carcinog. Risk Hum. 84 (2004) 1-512
21. Islander U., Erlandsson M.C., Hasseus B., Jonsson C.A., Ohlsson C., Gustafsson J.A., Dahlgren U., and Carlsten H. Influence of estrogen receptor alpha and beta on the immune system in aged female mice. Immunology 110 (2003) 149-157
22. Jacob J., Haug J.S., Raptis S., and Link D.C. Specific signals generated by the cytoplasmic domain of the granulocyte colony-stimulating factor (G-CSF) receptor are not required for G-CSF-dependent granulocytic differentiation. Blood 92 (1998) 353-361
23. Kobayashi M., Kawano S., Hatachi S., Kurimoto C., Okazaki T., Iwai Y., Honjo T., Tanaka Y., Minato N., Komori T., Maeda S., and Kumagai S. Enhanced expression of programmed death-1 (PD-1)/PD-L1 in salivary glands of patients with Sjogren's syndrome. J. Rheumatol. 32 (2005) 2156-2163
24. Kroner A., Mehlin M., Hemmer B., Rieckmann P., Toyka K.V., Maurer M., and Wiendl H. A PD-1 polymorphism is associated with disease progression in multiple sclerosis. Ann. Neurol. 58 (2005) 50-57
25. Lea C.K., Sarma U., and Flanagan A.M. Macrophage colony stimulating-factor transcripts are differentially regulated in rat bone-marrow by gender hormones. Endocrinology 140 (1999) 273-279
26. Lim S.K., Won Y.J., Lee H.C., Huh K.B., and Park Y.S. A PCR analysis of ERalpha and ERbeta mRNA abundance in rats and the effect of ovariectomy. J. Bone Miner. Res. 14 (1999) 1189-1196
27. Liu J., Xie Y., Cooper R., Ducharme D.M.K., Tennant R., Diwan B.A., and Waalkes M.P. Transplacental exposure to inorganic arsenic at a hepatocarcinogenic dose induces fetal gene expression changes in mice indicative of aberrant estrogen signaling and disrupted steroid metabolism. Toxicol. Appl. Pharmacol. 220 (2007) 284-291
28. Mencoboni M., Lerza R., Bogliolo G., Flego G., and Pannacciulli I. Effect of atrazine on hemopoietic system. In Vivo 6 (1992) 41-44
29. Medina K.L., Garrett K.P., Thompson L.F., Rossi M.I.D., Payne K.J., and Kinkade P.W. Identification of very early lymphoid precursors in bone marrow and their regulation by estrogen. Nat. Immunol. 2 (2001) 718-724
30. National Research Council, 2001. Arsenic in Drinking Water Update 0-309-07629-3. National Academy Press, Washington, D.C.
31. National Toxicology Program (NTP), 1994. NTP Report on the Immunotoxicity of Atrazine (CAS No. 1912-24-9) in Female B6C3F1 Mice (IMM94002).
32. O'Byrne K.J., and Dalgleish A.G. Chronic immune activation and inflammation as the cause of malignancy. Br. J. Cancer 85 (2001) 473-483
33. Okazaki T., and Honjo T. The PD-1-PD-L pathway in immunological tolerance. Trends Immunol. 27 (2006) 195-201 (review)
34. Pessina A., Albella B., Bueren J., Brantom P., Casati S., Gribaldo L., Croera C., Gagliardi G., Foti P., Parchment R., Parent-Massin D., Sibiril Y., and Van Den Heuvel R. Prevalidation of a model for predicting acute neutropenia by colony forming unit granulocyte/macrophage (CFU-GM) assay. Toxicol. In Vitro 15 (2001) 729-740
35. Pessina A., Malerba I., and Gribaldo L. Hematotoxicity testing by cell clonogenic assay in drug development and preclinical trials. Curr. Pharm. Des. 11 (2005) 1055-1065
36. Pessina A., Albella B., Bayo M., Bueren J., Brantom P., Casati S., Croera C., Gagliardi G., Foti P., Parchment R., Parent-Massin D., Schoeters G., Sibiril Y., Van Den Heuvel R., and Gribaldo L. Application of the CFU-GM assay to predict acute drug-induced neutropenia: an international blind trial to validate a prediction model for the maximum tolerated dose (MTD) of myelosuppressive xenobiotics. Toxicol. Sci. 75 (2003) 355-367
37. Pruett S.B., Fan R., Zheng Q., Myers L.P., and Hebert P. Modeling and predicting immunological effects of chemical stressors: characterization of a quantitative biomarker for immunological changes caused by atrazine and ethanol. Toxicol. Sci. 75 2 (2003) 343-354
38. Rahman M., Vahter M., Sohel N., Yunus M., Wahed M.A., Streatfield P.K., Ekström E.C., and Persson L.A. Arsenic exposure and age and sex-specific risk for skin lesions: a population-based case-referent study in Bangladesh. Environ. Health Perspect. 114 12 (2006) 1847-1852
39. Richards M.K., Liu F., Iwasaki H., Akashi K., and Link D.C. Pivotal role of granulocyte colony-stimulating factor in the development of progenitors in the common myeloid pathway. Blood 102 (2003) 3562-3568
40. Rodriguez V.M., Thiruchelvam M., and Cory-Slechta D.A. Sustained exposure to the widely used herbicide atrazine: altered function and loss of neurons in brain monoamine systems. Environ. Health Perspect. 113 (2005) 708-715
41. Rooney A.A., Matulka R.A., and Luebke R.W. Developmental atrazine exposure suppresses immune function in male, but not female Sprague-Dawley rats. Toxicol. Sci. 76 (2003) 366-375
42. Rowe A.M., Brundage K.M., and Barnett J.B. In vitro atrazine-exposure inhibits human natural killer cell lytic granule release. Toxicol. Appl. Pharmacol. 221 2 (2007) 179-188 [Epub February 7, 2007]
43. Sakurai T., Ohta T., Tomita N., Kojima C., Hariva Y., Mizukami A., and Fujiwara K. Evaluation of immunotoxic and immunodisruptive effects of inorganic arsenite on human monocytes/macrophages. Int. Immunopharmacol. 6 (2006) 304-315
44. Sharfe N., Freywald A., Toro A., Dadi H., and Roifman C. Ephrin stimulation modulates T cell chemiotaxis. Eur. J. Immunol. 32 (2002) 3745-3755
45. Shen J., Wanibuchi H., Waalkes M.P., Salim E.I., Kinoshita A., Yoshida K., Endo G., and Fukushima S.A. A comparative study of the sub-chronic toxic effects of three organic arsenical compounds on the urothelium in F344 rats; gender-based differences in response. Toxicol. Appl. Pharmacol. 210 3 (2006) 171-180
46. Shim G.J., Gherman D., Kim H.J., Omoto Y., Iwase H., Bouton D., Kis L.L., Andersson C.T., Warner M., and Gustafsson J.A. Differential expression of estrogen receptors in human secondary lymphoid tissues. J. Pathol. 208 (2006) 408-414
47. Stevens J.T., Breckenridge C.B., Wetzel L.T., Gillis J.H., Luempert III L.G., and Eldridge J.C. Hypothesis for mammary tumorigenesis in Sprague-Dawley rats exposed to certain triazine herbicides. J. Toxicol. Environ. Health 43 (1994) 139-153
48. Theus S.A., Lau K.A., Tabor D.R., Soderberg L.S., and Barnett J.B. In vivo prenatal chlordane exposure induces development of endogenous inflammatory macrophages. J. Leukoc. Biol. 51 4 (1992) 366-372
49. Tusher V.G., Tibshirani R., and Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 5116-5121
50. Vahter M., Akesson A., Liden C., Ceccatelli S., and Berglung M. Gender differences in the disposition and toxicology of metals. Environ. Res. 104 (2007) 85-95
51. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., and Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 18 (2002) 3-7
52. Van Merris V., Meyer E., Duchateau L., and Burvenich C. Differential effects of steroids and retinoids on bovine myelopoiesis in vitro. J. Dairy Sci. 87 5 (2004) 1188-1195
53. Viswanathan K., Liu L., Vaziri S., Dai E., Richardson J., Togonu-Bickersteth B., Vatsya P., Christov A., and Lucas A.R. Myxoma viral serpin, Serp-1, a unique interceptor of coagulation and innate immune pathways. Thromb. Haemost. 95 (2006) 499-510
54. Waalkes M.P., Ward J.M., Liu J., and Diwan B.A. Transplacental carcinogenicity of inorganic arsenic in the drinking water: induction of hepatic, ovarian, pulmonary, and adrenal tumors in mice. Toxicol. Appl. Pharmacol. 186 (2003) 7-17
55. Waalkes M.P., Liu J., Chen H., Xie Y., Achanzar W.E., Zhou Y.S., Cheng M.L., and Diwan B.A. Estrogen signaling in livers of male mice with hepatocellular carcinoma induced by exposure to arsenic in utero. Natl. Cancer Inst. 966 (2004) 466-474
56. Wetzel L.T., Luempert III L.G., Breckenridge C.B., Tisdel M.O., Stevens J.T., Thakur A.K., Extrom P.J., and Eldridge J.C. Chronic effects of atrazine on estrus and mammary tumor formation in female Sprague-Dawley and Fischer 344 rats. J. Toxicol. Environ. Health 43 (1994) 169-182
57. WHO. Arsenic and Arsenic Compounds. Environmental Health Criteria 224 (2001), World Health Organization, Geneva
58. WHO, 2002. Principles and Methods for the Assessment of Risk From Essential Trace Elements. IPCS No. 228. World Health Organization.
59. Woods J.S., and Fowler B.A. Effects of chronic arsenic exposure on hematopoietic function in adult mammalian liver. Environ. Health Perspect. 19 (1977) 209-213